Port Access Needles Market Report
Industry revenue for Port Access Needles is estimated to rise to $2162.9 million by 2035 from $781.2 million of 2024.
Global Port Access Needles Powerhouses: Top 5 Countries Driving Growth
According to recent research by DataString Consulting, the Port Access Needles market is projected to grow from $781.2 million in 2024 to $2,162.9 million by 2035. The U.S., Germany, UK, Japan, and China are the top 5 markets, collectively commanding a substantial demand share. Market players in these countries are expected to see revenue growth ranging between 7.1% and 10.2% annually from 2025 to 2035.
Biomedical Advancements Transforming the Market
Technology Shift in Port Access Needles
The field of biomedical engineering has driven notable innovations in Port Access Needle technology. These include:
Enhanced patient comfort
Reduced infection risks
Improved drug delivery precision
Port Access Needles are now more efficient for administering medications like chemotherapy drugs, antibiotics, and parenteral nutrition, especially in oncology where they are extensively used for repeated infusion procedures.
Key Application Areas
Parenteral Nutrition
Port Access Needles are essential for patients who cannot eat orally. Non-coring needles are preferred for minimizing damage to the port septum. Market Leaders: AngioDynamics, Nipro Medical Corporation
Blood Transfusion
Used for delivering blood and blood products directly into the bloodstream, these needles must accommodate patient-specific needs, including condition and required volume.
Market Leaders & Strategic Initiatives
The Port Access Needles market is highly competitive with key players focusing on innovation, quality, and expansion. Major companies include:
Becton Dickinson and Company
Smiths Medical
Nipro Corporation
B. Braun Melsungen AG
AngioDynamics Inc.
Teleflex Incorporated
Vygon S.A.
Cook Medical
Medtronic plc
Argon Medical Devices Inc.
Boston Scientific Corporation
Terumo Corporation
Leading Provider
Key Strategy
Becton, Dickinson and Company
Product innovation and quality assurance to ensure patient safety and comfort
Smiths Medical
Development of reliable, user-friendly products for healthcare professionals
Medtronic
Heavy R&D investment in advanced, efficient port access needle technologies
AngioDynamics
Strategic partnerships and acquisitions to grow product portfolio and reach
Access the Full Report
📘 Detailed Insights: https://datastringconsulting.com/industry-analysis/port-access-needles-market-research-report
📥 Download Free Sample: https://datastringconsulting.com/downloadsample/port-access-needles-market-research-report
Report Scope Overview
Segment
Subsegments
Product Type
Single Lumen, Double Lumen
Therapeutic Apps
Oncology, Hematology, Gastroenterology, Others
End-User
Hospitals, Ambulatory Surgical Centers, Homecare, Others
Distribution
Direct Sales, Retail, Online Sales
About DataString Consulting
DataString Consulting provides a comprehensive suite of market intelligence solutions for both B2B and B2C sectors. From tailored insights to fully customized reports, we help organizations align with strategic goals and market realities.
Trusted by Fortune 500 companies
Reports starting at just USD 1,399
Collaborative, cost-efficient research delivery model
Contact Us
Mr. Mark Lawson DataString Consulting 📧 mlawson@datastringconsulting.com 📧 sales@datastringconsulting.com
Last updated